Astrazeneca Share News (AZN)

Rare vaccine-related blood clots tied to gene; concentrated antibodies may help the immunosuppressed

April 6 (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.

UK shares break 3-day winning streak on U.S. rate hike worries

April 6 (Reuters) - Britain's main stock indexes snapped three sessions of gains on Wednesday as investors feared an aggressive U.S. monetary policy tightening and new Western sanctions on Russia would slow economic growth.

Deutsche Bank hikes AstraZeneca target price despite rising rate environment

(Sharecast News) - Analysts at Deutsche Bank hiked their target price for shares of AstraZeneca, telling clients they saw no reason to tilt towards so-called 'value' names in the space and away from 'growth'.

LONDON BROKER RATINGS: Berenberg cuts Polymetal and raises Hochschild

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

FTSE 100 rises on healthcare, utilities boost

April 5 (Reuters) - London's FTSE 100 index edged higher on Tuesday powered by healthcare and utility stocks, while investors closely tracked the prospect of more Western sanctions against Russia over the war in Ukraine.

AstraZeneca's AZD8233 shows positive results for hypercholesterolemia

(Alliance News) - AstraZeneca PLC announced positive results from its Etesian phase IIb trial on Monday, which met its primary and secondary endpoints.

Industrials and leisure stocks boost UK shares higher; Ted Baker rallies

April 4 (Reuters) - Gains in industrials and leisure stocks drove Britain's share indexes higher on Monday, with investors closely tracking developments around the Russia-Ukraine crisis, while fashion retailer Ted Baker jumped after launching a formal sale process.

Vaccination after COVID improves immunity; ivermectin fails in major trial

April 1 (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.

Vaccination after COVID-19 improves immunity

New cancer immunotherapy fails in first Roche trial

March 30 (Reuters) - A highly anticipated new cancer immunotherapy by Roche failed to slow the progression of an aggressive form of lung cancer, the Swiss drug maker said on Wednesday, boding ill for a range of rival drug developers working on similar compounds.

AstraZeneca's Ondexxya approved in Japan to treat major bleeds

(Alliance News) - AstraZeneca PLC on Tuesday said its reversal agent Ondexxya has been fully approved in Japan for reversal of acute major bleeds in some patients.

AstraZeneca's Ondexxya receives Japanese approval

(Sharecast News) - Drugmaker AstraZeneca revealed on Tuesday that its Ondexxya asset had become the first approved medicine in Japan to specifically reverse the anticoagulant effect of Factor Xa inhibitors, providing "a major advance" in the treatment of patients hospitalised with life-threatening bleeding.

TOP NEWS: AstraZeneca's Evusheld backed in EU for Covid-19 prevention

(Alliance News) - AstraZeneca PLC said on Monday that its Evusheld antibody combination for Covid-19 prevention has been granted marketing authorization in the EU.

AstraZeneca Covid drug gets EU approval

(Sharecast News) - The European Union has given marketing approval to AstraZeneca's Evusheld coronavirus medicine for adults and children over 12 years old, the company said on Monday.

LONDON MARKET PRE-OPEN: Barclays warns of hit; Astra Covid drug backed

(Alliance News) - Stock prices in London are seen opening ever-so slightly higher on Monday in a cautious start to the new week, with markets tracking geopolitical developments and rising Covid-19 cases in China, while also awaiting fresh drivers in a quiet day in the economic calendar.

UPDATE: EU drug watchdog approves AstraZeneca Covid prevention jab

(Alliance News) - The EU's drug watchdog on Thursday recommended for approval AstraZeneca PLC's Covid-19 prevention cocktail, which can be used for patients with immune system problems or severe reactions to other coronavirus vaccines.